Safety, Side Effects and Contraindications All three options are described as generally well tolerated
To address this limitation, various long-acting GLP-1 analogues have been developed, designed to prolong in vivo efficacy and enhance therapeutic potential (Table 1)
IH has received nonfinancial support from AstraZeneca/Bristol Myers Squibb, Dexcom, GlaxoSmithKline, Insulet Corp., Janssen, Lexicon Pharmaceuticals, Medtronic, Merck & Co., Novo Nordisk, the Population Health Research Institute and Sanofi
Patients with active cancer, untreated hypothyroidism, or pituitary disorders require specialist evaluation before starting any growth hormone secretagogue
Rights and permissions About this article Cite this article Damsky, W., Bosenberg, M
Related Stories Review highlights pregnancy and miscarriage rates among transmasculine people Midpregnancy herbicide exposure linked to increased risk of preterm birth Prenatal use of certain medications can harm developing fetal brain The most frequently reported drugs were semaglutide and liraglutide, followed by exenatide and dulaglutide